Foreign Trials, U.S. Liability: Pfizer Dealt Setback As Solicitor General Asks Supreme Court Not To Review Nigerians' Trovan Suit
This article was originally published in The Pink Sheet Daily
Executive Summary
If the Supreme Court lets appeals court decision stand, pharmaceutical firms could find themselves facing more litigation regarding clinical trials conducted overseas.
You may also be interested in...
Clinical Trial Liability: Attorneys And Consultants Offer Tips On Reducing Risk
As the number of clinical trials proliferate, so too do the situations that can lead to litigation
Clinical Trial Liability: Attorneys And Consultants Offer Tips On Reducing Risk
As the number of clinical trials proliferate, so too do the situations that can lead to litigation
Out Of Africa: Why A Court Decision On Trovan Affects Pharma
Last month, a federal appeals panel jolted Pfizer by ruling that dozens of Nigerians can sue the drugmaker in a U.S. court over its handling of a 1996 clinical trial for its Trovan (trovafloxacin mesylate) antibiotic